EUVIMEDObjevte EUVIMED
Video/Audio

Engineering Chimeric Antigen Receptor-Natural Killer Cells Targeting Fungal Infections Using the Non-viral Sleeping Beauty Transposon System

Maximilian Bauser, Hermann Einsele, Jürgen Löffler, Michael Hudecek, Michelle Seif

Journal of Visualized Experiments · 2024

DOI: 10.3791/67424 ↗

At a glance

Video/Audio in Journal of Visualized Experiments, 2024. Written by Maximilian Bauser and 4 co-authors. Institution: Medizinische Klinik und Poliklinik II und Lehrstuhl für Zelluläre Immuntherapie, Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg. Major MEDLINE topics: Killer Cells, Natural, Receptors, Chimeric Antigen, DNA Transposable Elements. Cited 6 times so far (Crossref); 20 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Chimeric antigen receptor (CAR)-based cell therapies have shown impressive efficacy in the treatment of hematological malignancies. Recently, these therapies are being developed for infectious diseases, yet studies targeting fungal infections remain scarce. To identify optimal targets and optimize cellular products, we developed a method to engineer chimeric antigen receptor-natural killer (CAR-NK) cells and evaluated their response to stimulation by fungi. This paper describes a straightforward and robust method for generating CAR-NK cells tailored to fungal targets using the non-viral Sleeping Beauty transposon system. NK-92 cells are transfected with the hyperactive transposase SB100X vectorized as minicircle DNA (MC) along with a plasmid-encoded CAR transposon. Transfection efficiency is assessed 1 week later using flow cytometric analysis. Prior to functional testing, the cells expressing the transgene are enriched using magnetic-activated cell sorting and cultured for 1 more week. To evaluate antigen-specific activation, the engineered cells are co-cultured with Aspergillus fumigatus germ tubes for at least 6 h. Subsequently, the concentration of the secreted interferon-gamma (IFN-γ) is measured using an enzyme-linked immunosorbent assay.

Subjects

MeSH terms (MEDLINE)

Killer Cells, NaturalReceptors, Chimeric AntigenDNA Transposable ElementsHumansTransposasesAspergillus fumigatusTransfectionImmunotherapy, Adoptive

Substances

Receptors, Chimeric AntigenDNA Transposable ElementsTransposasessleeping beauty transposase, human

Authors and institutions

  • Medizinische Klinik und Poliklinik II und Lehrstuhl für Zelluläre Immuntherapie, Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg.
  • Medizinische Klinik und Poliklinik II und Lehrstuhl für Zelluläre Immuntherapie, Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg; Fraunhofer-Institut für Zelltherapie und Immunologie IZI, Außenstell…
  • Medizinische Klinik und Poliklinik II und Lehrstuhl für Zelluläre Immuntherapie, Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg; Seif_M@ukw.de.

Cite

APA

Bauser, M., Einsele, H., Löffler, J., Hudecek, M., & Seif, M. (2024). Engineering Chimeric Antigen Receptor-Natural Killer Cells Targeting Fungal Infections Using the Non-viral Sleeping Beauty Transposon System. Journal of Visualized Experiments. https://doi.org/10.3791/67424

Vancouver

Bauser M, Einsele H, Löffler J, Hudecek M, Seif M. Engineering Chimeric Antigen Receptor-Natural Killer Cells Targeting Fungal Infections Using the Non-viral Sleeping Beauty Transposon System. Journal of Visualized Experiments. 2024. doi:10.3791/67424

BibTeX
@article{Bauser2024,
  author = {Bauser, Maximilian and Einsele, Hermann and Löffler, Jürgen and Hudecek, Michael and Seif, Michelle},
  title = {Engineering Chimeric Antigen Receptor-Natural Killer Cells Targeting Fungal Infections Using the Non-viral Sleeping Beauty Transposon System},
  journal = {Journal of Visualized Experiments},
  year = {2024},
  doi = {10.3791/67424}
}
Start for free →